Drug profile

The FDA adverse-event record for Cranberry Tablets

19 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cranberry Tablets. See the species affected, top reactions, and outcomes below.

19
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
8
Urinary tract infection - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Cranberry Tablets

Administration Routes

OralUnknown

Species Affected

Dog 19

Most Affected Breeds

Terrier - Yorkshire 2
Shepherd Dog - Australian 2
Crossbred Canine/dog 1
Shih Tzu 1
Corgi (unspecified) 1
Terrier - West Highland White 1
Retriever - Flat-coated 1
Pug 1
Shepherd Dog - German 1
Spaniel (unspecified) 1

Most Reported Reactions

Urinary tract infection 8
Lethargy (see also Central nervous system depression in 'Neurological') 7
Anorexia 3
Polyuria 2
Haematuria 2
Polydipsia 2
Decreased appetite 2
Urine abnormalities NOS 2
Crystalluria 2
Behavioural disorder NOS 2
Other abnormal test result NOS 2
Lack of efficacy - NOS 2

Outcome Breakdown

Ongoing
14 (73.7%)
Outcome Unknown
4 (21.1%)
Recovered/Normal
1 (5.3%)

Cranberry Tablets Adverse Event Insights

19 reports name Cranberry Tablets; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Cranberry Tablets. Administration routes: Oral, Unknown.

By species: Dog (19 reports). By breed: Terrier - Yorkshire (2), Shepherd Dog - Australian (2), Crossbred Canine/dog (1).

Leading clinical signs: Urinary tract infection (8), Lethargy (see also Central nervous system depression in 'Neurological') (7), Anorexia (3), Polyuria (2). Outcome, 19 coded reports: Ongoing leads at 73.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.